Pain related to Optiva 2, Biovalve, and Venflon 2 intravenous catheters.
Pain related to the insertion of intravenous catheters is a major issue for many patients. This study investigated differences in pain on insertion for three different catheters - Optiva 1, Biovalve and Venflon 2 - as assessed by 100 volunteers. Clinicians also assessed a variety of parameters related to their overall ease of use. This study demonstrates that Optiva 2 can offer significant benefits for both patient and clinician. Pain on insertion was significantly lower with Optiva 2 than with Venflon 2, but comparable with Biovalve. Ease of insertion and flashback were significantly better for Optiva 2 than for Venflon 2, but similar to Biovalve. For the parameters 'ease of catheter advancement' and 'overall ease of use', the operators rated Optiva 2 significantly better than Biovalve and Venflon 2.
Lücker
Peter
P
Institut für Klinische Pharmakologie Bobenheim.
Stahlheber-Dilg
Bodo A
BA
D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D002406:Catheterization, Peripheral / Q000295:instrumentation*; D002408:Catheters, Indwelling / Q000009:adverse effects* / Q000592:standards; D003288:Contusions / Q000175:diagnosis / Q000209:etiology; D004867:Equipment Design; D004868:Equipment Failure; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000175:diagnosis / Q000209:etiology*; D010147:Pain Measurement; D011138:Polytetrafluoroethylene; D011140:Polyurethanes
D011140:Polyurethanes; D011138:Polytetrafluoroethylene